Paper42907643PubMed
Analytical Insights and Biomedical Applications of Homing Penetrating Peptides in Cancer.
Darie-Ion L and 2 others. Adv Exp Med Biol, 2026.
Cite this record
ConductScience Library. Analytical Insights and Biomedical Applications of Homing Penetrating Peptides in Cancer. Papers, record 42907643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42907643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analytical Insights and Biomedical Applications of Homing Penetrating Peptides in Cancer.
- Journal
- Adv Exp Med Biol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-22
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11734621 | Estrogen receptors and proliferation markers in primary and recurrent breast cancer. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11734621 | PubMed |
| 2 | 16301830 | VEGF as a key mediator of angiogenesis in cancer. | Oncology | 2005 | https://conductscience.org/library/papers/16301830 | PubMed |
| 3 | 22846215 | Permissive role of endothelin receptors in tumor metastasis. | Life Sci | 2012 | https://conductscience.org/library/papers/22846215 | PubMed |
| 4 | 9496384 | Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. | Ann Oncol | 1997 | https://conductscience.org/library/papers/9496384 | PubMed |
| 5 | 28799536 | Estrogen receptor (ESR1) mutation in bone metastases from breast cancer. | Mod Pathol | 2018 | https://conductscience.org/library/papers/28799536 | PubMed |
| 6 | 33543454 | Homing Peptides for Cancer Therapy. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/33543454 | PubMed |
| 7 | 28544932 | Vascular-homing peptides for cancer therapy. | Biomed Pharmacother | 2017 | https://conductscience.org/library/papers/28544932 | PubMed |
| 8 | 24533809 | Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics. | Curr Med Chem | 2014 | https://conductscience.org/library/papers/24533809 | PubMed |
| 9 | 37389978 | Cell Penetrating Peptides: Classification, Mechanisms, Methods of Study, and Applications. | ChemMedChem | 2023 | https://conductscience.org/library/papers/37389978 | PubMed |
| 10 | 28209404 | Cell-Penetrating Peptides: From Basic Research to Clinics. | Trends Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28209404 | PubMed |
| 11 | 38892406 | Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892406 | PubMed |
| 12 | 40672665 | Advancing Cancer-Targeted Nanotherapies with Tumor Homing Peptides. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40672665 | PubMed |
| 13 | 23986882 | Tumor-penetrating peptides. | Front Oncol | 2013 | https://conductscience.org/library/papers/23986882 | PubMed |
| 14 | 19833724 | Translocation and endocytosis for cell-penetrating peptide internalization. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19833724 | PubMed |
| 15 | 22472979 | Do cell-penetrating peptides actually "penetrate" cellular membranes? | Mol Ther | 2012 | https://conductscience.org/library/papers/22472979 | PubMed |
| 16 | 40856125 | Cell-penetrating peptides as facilitators of cargo-specific nanocarrier-based drug delivery. | Nanoscale | 2025 | https://conductscience.org/library/papers/40856125 | PubMed |
| 17 | 38105200 | Cell-Penetrating Peptides as Vehicles for Delivery of Therapeutic Nucleic Acids. Mechanisms and Application in Medicine. | Biochemistry (Mosc) | 2023 | https://conductscience.org/library/papers/38105200 | PubMed |
| 18 | 37631307 | Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37631307 | PubMed |
| 19 | 27713270 | Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy. | Pharmaceuticals (Basel) | 2010 | https://conductscience.org/library/papers/27713270 | PubMed |
| 20 | 33224505 | Ultralong tumor retention of theranostic nanoparticles with short peptide-enabled active tumor homing. | Mater Horiz | 2019 | https://conductscience.org/library/papers/33224505 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42907643
GET https://conductscience.org/api/papers/v1/42907643/references?page=2